From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Immunosuppressive drugs have been used in the treatment of multiple sclerosis (MS) for a long time. Today, orally available second generation immunosuppressive agents have been approved or are filed for licensing as MS therapeutics. Due to semi-selective targeting of cellular processes, these second...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | Revisão |
| 语言: | 英语 |
| 出版: |
2017
|
| 在线阅读: | https://doi.org/10.2174/1570159x14666161208151525 |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|